Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share of Common Shares (Details) - Schedule of diluted loss per share due to being anti-dilutive

v3.20.2
Loss Per Share of Common Shares (Details) - Schedule of diluted loss per share due to being anti-dilutive - shares
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Loss Per Share of Common Shares (Details) - Schedule of diluted loss per share due to being anti-dilutive [Line Items]    
Anti-diluted loss share 1,152,622 3,343,168
Warrants [Member]    
Loss Per Share of Common Shares (Details) - Schedule of diluted loss per share due to being anti-dilutive [Line Items]    
Anti-diluted loss share 332,014
Stock options [Member]    
Loss Per Share of Common Shares (Details) - Schedule of diluted loss per share due to being anti-dilutive [Line Items]    
Anti-diluted loss share 820,608 630,402
Series A preferred stock {Member]    
Loss Per Share of Common Shares (Details) - Schedule of diluted loss per share due to being anti-dilutive [Line Items]    
Anti-diluted loss share 2,438,866
Series A preferred stock {Member] | Warrants [Member]    
Loss Per Share of Common Shares (Details) - Schedule of diluted loss per share due to being anti-dilutive [Line Items]    
Anti-diluted loss share 273,900